Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis

  Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith, Rhodri Saunders

Keywords: targeted therapy; turnaround time; health economic analysis; hospital costs; genetic testing; return on investment; USA

  Journal of Health Economics and Outcomes Research

https://jheor.org/article/77686-fast-in-house-next-generation-sequencing-in-the-diagnosis-of-metastatic-non-small-cell-lung-cancer-a-hospital-budget-impact-analysis